Effect of Cross‐Sex Hormonal Replacement on Antioxidant Enzymes in Rat Retroperitoneal Fat Adipocytes

Abstract

We report the effect of cross-sex hormonal replacement on antioxidant enzymes from rat retroperitoneal fat adipocytes. Eight rats of each gender were assigned to each of the following groups: control groups were intact female or male (F and M, resp.). Experimental groups were ovariectomized F (OvxF), castrated M (CasM), OvxF plus testosterone (OvxF + T), and CasM plus estradiol (CasM + E2) groups. After sacrifice, retroperitoneal fat was dissected and processed for histology. Adipocytes were isolated and the following enzymatic activities were determined: Cu-Zn superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione-S-transferase (GST), and glutathione reductase (GR). Also, glutathione (GSH) and lipid peroxidation (LPO) were measured. In OvxF, retroperitoneal fat increased and adipocytes were enlarged, while in CasM rats a decrease in retroperitoneal fat and small adipocytes are observed. The cross-sex hormonal replacement in F rats was associated with larger adipocytes and a further decreased activity of Cu-Zn SOD, CAT, GPx, GST, GR, and GSH, in addition to an increase in LPO. CasM + E2 exhibited the opposite effects showing further activation antioxidant enzymes and decreases in LPO. In conclusion, E2 deficiency favors an increase in retroperitoneal fat and large adipocytes. Cross-sex hormonal replacement in F rats aggravates the condition by inhibiting antioxidant enzymes.

Cytidine‐5'‐Diphosphocholine Protects the Liver From Ischemia/Reperfusion Injury Preserving Mitochondrial Function and Reducing Oxidative Stress

“…*P < 0.05 versus control and ** P < 0.05 versus I/R. in hyperglycemic rats, (37) and maintain the activity of aconitase, an Fe-S cluster enzyme considered a reliable marker of oxidant damage in mitochondria, (14) supporting our assumption that its antioxidant effect stabilizes mitochondrial function. However, we did not find changes in mitochondrial GSH levels.…”

Androgen Therapy in Neurodegenerative Diseases

“…Low serum T levels represent a predisposing risk factor involved in various neurodegenerative diseases. Androgens could play an essential role in the prevention and treatment of neurodegenerative diseases because of their anti-inflammatory effects, which include the inhibition of proinflammatory cytokines production [ 262 ], protection from oxidative stress (thereby increasing Cu-Zn SOD activity in adipocytes [ 263 ], and modulation of Aβ formation). However, clinical studies conducted in patients with AD have provided conflicting results.…”

Reductive Stress in Inflammation-Associated Diseases and the Pro-Oxidant Effect of Antioxidant Agents

“…In cell systems, when the antioxidant enzyme catalase (CAT) is overexpressed in the cytoplasmic or mitochondrial compartments, there is potentiated apoptosis [ 10 ]. In contrast, inhibition of endogenous CAT promotes cell survival [ 11 ]. Additional studies have tied the CAT-induced decrease in H 2 O 2 with diminished activation of NF-κB survival pathways.…”

“…GSH is a tripeptide formed by glutamate, cysteine, and glycine, having a low molecular weight that has been widely used as an indicator of the cellular redox state, and has been implicated in several pathologies. It is synthetized by γ-glutamyl-cysteine synthetase (GCL), GSH synthetase, and regenerated by glutathione reductase (GR) [ 11 ]. GSH is the endogenous intracellular antioxidant found in a higher concentration within cells that acts against ROS and electrophiles, and is one of the main mechanisms for the antioxidant defense.…”